Abstract: A device which comprises an enclosure of a plastics material, having an opening at an end thereof with fastening means to enable the opening to be closed around a limb or stump with an affected part contained within the enclosure, and including a fluid-absorbent material within the enclosure. The device is particularly suitable for use in the treatment of leg ulcers.
Abstract: The present invention pertains to a novel transmembrane protein capable of binding to biotinylated molecules, the protein comprising a cytoplasmic domain, a membrane-spanning domain and an extracellular domain, wherein the extracellular domain comprises biotin-binding activity.
Type:
Grant
Filed:
July 11, 2003
Date of Patent:
April 24, 2007
Assignee:
Ark Therapeutics Limited
Inventors:
Seppo Yla-Herttuala, Markku Kulomaa, Pauliina Lehtolainen, Varpu Marjomaki, Kari Airenne
Abstract: It has been found that inhibitors of the renin-angiotensin system are useful for the treatment or prevention of conditions associated with hypoxia or impaired metabolic function or efficiency. In particular, they may be used in connection with therapy of stroke or its recurrence, the acute treatment of myocardial infarction, and the treatment or prevention of wasting or cachexia, and are thus useful in treatment of the symptoms and signs of aging. These inhibitors may also be used to enhance function in healthy subjects.
Type:
Grant
Filed:
July 26, 2002
Date of Patent:
July 4, 2006
Assignee:
Ark Therapeutics Limited
Inventors:
Hugh Edward Montgomery, John Francis Martin, Jorge Daniel Erusalimsky